Pharmacokinetics of Carbapenem Antibiotics in Obese Patients.

NCT01407965 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2016-10-17

No results posted yet for this study

Summary

Tissue kinetics of ertapenem and meropenem in fatty tissue, intraperitoneal fluid and plasma.

Conditions

Interventions

PROCEDURE

microdialysis catheter

Placing of microdialysis catheter in fatty tissue and in the peritoneal cavity

PROCEDURE

microdialysis catheter

Placing of microdialysis catheter in fatty tissue and in the peritoneal cavity

Sponsors & Collaborators

  • University of Ulm

    lead OTHER

Principal Investigators

  • Doris Henne-Bruns, PhD · University of Ulm

  • Mathias Wittau, Dr. · University of Ulm

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01407965 on ClinicalTrials.gov